While they still trade at premium valuations, they have not created wealth for shareholders. The fact is an age-old theory that just having...

In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...

Manchanda added that the anti-infectives treating HIV, TB and drug cessation treatments in the list doesn't have a major impact on margins ...

There has been no sign of community transmission yet, the Health ministry said even as India's Covid numbers inched closer to the 7,000-mar...

“We have recently received final approval for rifapentine from the Indian regulatory authorities. Rifapentine is now officially registered ...

India carries the highest burden of TB with about 2.69 mn cases in 2018. About 40% of the country’s population is estimated to have latent ...

In a landmark development, global biopharmaceutical company Sanofi will lower the price of Rifapentine, a critically important drug used to...

Last week, NPPA announced that it plans to bring an additional 50 drugs belonging to the cardiovascular and anti-diabetic segment under pri...

On Friday, the National Pharmaceutical Pricing Authority (NPPA) slashed the prices of 108 brands under a provision of the Drug Pricing Cont...

Drug major Lupin said it has received US health regulator's approval to market a generic version of Sanofi Aventis' Rifadin capsules.

A bird flu vaccine for humans that uses only a very low dose of active ingredient has proved effective in clinical tests and could be mass ...